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	 Mixed‐ligand	 bivalent	 transition	 metal	 ion	 complexes	 with	 N‐ethyl‐2‐picolinoyl
hydrazinecarbothioamide	 (EPHC)	 and	 1,10‐phenanthroline	 (1,10‐phen)	 have	 been
synthesized.	 The	 complexes	 namely	 [Cu(EPHC)(1,10‐phen)(Cl)H2O]	 (1),	 [Ni(EPHC)(1,10‐
phen)(Cl)H2O]	 (2),	 [Mn(EPHC)(1,10‐phen)(Cl)H2O]	 (3)	 and	 [Co(EPHC)(1,10‐phen)(Cl)H2O]
(4)	were	characterized	by	elemental	analysis,	spectral	(IR,	1H	NMR	and	UV‐Vis)	and	magnetic
moment	measurements.	The	magnetic	and	spectral	data	indicates	octahedral	structure	for	all
complexes.	 Metal	 complexes	 have	 been	 modeled	 using	 parameterized	 PM3	 semi‐empirical
method.	 The	 free	 ligand	 and	 its	 M(II)‐chelates	 have	 been	 screened	 for	 their	 antimicrobial
activities.	 The	 antibacterial	 screening	 demonstrated	 that,	 the	 Cu(II)	 complex	 have	 the
maximum	and	broad	activities	among	the	investigated	complexes.	
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1.	Introduction	
	
Thiosemicarbazones	have	been	extensively	studied	because	
they	 have	 a	 wide	 range	 of	 actual	 or	 potential	 medical	
applications	 [1‐3]	 which	 include	 notably	 antiparasital	 [3],	
antibacterial	[4]	antitumor	activities	[5],	antiviral	[6],	fungicidal	
[7]	and	antineoplastic	[8].	Thiosemicarbazones	derived	from	2‐
picolinic	 acid	 hydrazide	 and	 its	 derivatives	 are	 classes	 of	
versatile	 tridentate	 NNS	 donors	 capable	 of	 stabilizing	 both	
higher	 and	 lower	 oxidation	 states	 of	 transition	 metal	 ions	
[9,10].	 In	 general,	 thiosemicarbazones	 are	 obtained	 by	
condensation	 of	 the	 corresponding	 thiosemicarbazide	 with	
aldehydes	or	ketones.	Thiosemicarbazones	(TSCNs)	exist	in	the	
tautomeric	thione	(A)	and	thiol	(B)	forms	(Scheme	1).		
	
	
																		(A)																																																																										(B)	
	
Scheme	1	
	
The	chemistry	of	transition	metal	complexes	of	heterocyclic	
thiosemicarbazone	 ligands	 have	 been	 receiving	 considerable	
attention	 primarily	 because	 of	 their	 bioinorganic	 relevance	
[11,12].	 There	 have	 been	 attempts	 to	 determine	 structural	
correlation’s	 between	 transition	 metal	 ion	 complexes	 of	
heterocyclic	 thiosemicarbazones	 and	 their	 wide	 spectrum	 of	
biological	 applications	 [13].	 In	 several	 cases,	 the	 pharma‐
cological	 action	 of	 the	 thiosemicarbazons	 is	 enhanced	 due	 to	
their	 ability	 to	 chelate	 transition	metal	 ions	 [14,15].	 It	 is	well	
authenticated	 that	a	NNS	 tridentate	 system	 is	present	 in	most	
of	 the	 thiosemicarbazones	 having	 carcinostatic	 potency	 and	
possessing	 substantial	 in	 vitro	 activity	 against	 various	 human	
tumor	 lines	 [16,17].	 In	 the	 past,	 it	 has	 been	 shown	 that	 the	
metal	complexes	are	more	effective	than	their	parent	ligands	in	
anticancer	 activity	 [18,19].	 The	 inhibitory	 action	 of	 these	
compounds	 is	 attributed	 to	 their	 chelating	 properties	 to	
different	 metal	 ions	 that	 can	 be	 found	 in	 biological	 systems	
[20].	Additionally,	one	of	the	many	reasons	is	that	the	binding	
affinity	 of	 metals	 to	 proteins	 or	 enzymes	 will	 change	 the	
interaction	 process	 of	 them	 with	 DNA,	 thereby	 affecting	 the	
DNA	replication	and	cell	proliferation	[19].		
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Scheme	2	
	
	
 
	
Scheme	3
	
	
Earlier	 studies	 on	 the	 biological	 properties	 of	
thiosemicarbazones	and	their	metal	complexes	have	concluded	
that	 the	 biologically	 active	 thiosemicarbazone	 molecules	 are	
planar	and	contain	a	pyridine	ring	or	derivatives	giving	rise	to	
NNS	 tridentate	 system	 [21,22].	 1,10‐Phenanthroline	 is	 the	
parent	of	an	 important	class	of	chelating	agents.	The	choice	of	
phenanthroline	 is	 mainly	 due	 to	 two	 factors.	 This	 hetero‐
aromatic	 moiety	 can	 provide	 a	 further	 binding	 site	 for	 metal	
cations.	It	is	rigid,	and	provides	two	aromatic	nitrogens	whose	
unshared	 electron	 pairs	 can	 act	 co‐operatively	 in	 binding	
cations	[23].	Moreover,	1,10‐phenanthroline,	the	ligand	moiety	
of	 the	 ternary	 complexes	 presented	 in	 this	 work	 is	 of	
considerable	 interest	 also	 according	 to	 the	 biological	 or	
pharmacological	 properties	 (antifungal,	 antimycoplasma	 and	
antiviral)	of	some	of	its	metal	complexes	[24].		
With	 this	 in	 mind,	 it	 seems	 therefore	 of	 considerable	
interest	 to	 synthesize	 and	 characterize	 M(II)	 complexes	 with	
the	 novel	 N‐ethyl‐2‐picolinoylhydrazinecarbothioamide	
(EPHC)	 and	 1,10‐phenanthroline	 (1,10‐phen)	 with	 different	
bivalent	 transition	metal	 ions	 Co(II),	 Cu(II),	Mn(II)	 and	Ni(II).	
Additionally,	 our	 objective	 is	 also	 to	 study	 the	 antibacterial,	
antifungal	 and	 antitumor	 activities	 of	 the	 synthesized	
compounds.		
	
2.	Experimental		
	
2.1.	Materials	and	instrumentation		
	
All	 starting	 materials	 were	 purchased	 from	 Fluka,	 Riedel	
and	Merck	and	used	as	received.	The	analyses	were	performed	
twice	 to	 check	 the	 accuracy	 of	 the	 analyses	 data.	 Infrared	
spectra	were	recorded	on	FT‐IR	Shimadzu	spectrophotometer	
(8001‐PC)	using	KBr	pellets.	The	solid	reflectance	spectra	were	
measured	 on	 a	 Shimadzu	 3101	 PC	 spectrophotometer.	 The	
room	 temperature	 magnetic	 susceptibility	 measurements	 for	
the	 complexes	 were	 determined	 by	 the	 Gouy	 balance	 using	
Hg[Co(SCN)4]	as	a	 calibrant.	Electron	paramagnetic	 resonance	
(EPR)	has	matured	 into	a	powerful,	versatile,	non‐destructive,	
and	 non‐intrusive	 analytical	 method.	 EPR	 signals	 were	
recorded	 at	 room	 temperature	 by	 using	 a	 Bruker	 EMX	
spectrometer	 (X‐band)	 product	 of	 Bruker,	 Germany.	 The	
operating	 conditions	 are,	 microwave	 power	 =	 0.201	 mW,	
modulation	 amplitude	 =	 4.00	 Gauss,	 modulation	 frequency	 =	
100	 kHz,	 sweep	 width	 =	 200	 Gauss,	 microwave	 frequency	 =	
9.775	GHz,	time	constant	=	81.92	ms	and	sweep	time	=	20.97	s.	
The	detection	 limits	of	EPR	 technique	depends	on	 the	 type	of	
sample,	 sample	 size,	 detector	 sensitivity,	 frequency	 of	 the	
incident	microwave	radiation.	
2.2.	Synthesis	
	
2.2.1.	Synthesis	of	N‐ethyl‐2‐picolinoylhydrazine	
carbothioamide	(EPHC)	
N‐Ethyl‐2‐picolinoylhydrazinecarbothioamide	 (EPHC)	 is	
prepared	in	two	steps	as	follow:	
Step	1:	Preparation	of	2‐picolinic	acid	hydrazide		
2‐Picolinic	acid	hydrazide	was	prepared	by	refluxing	ethyl	
picolinate	and	hydrazine	hydrate	as	shown	in	Scheme	2.	
Step	2:	Preparation	of	N‐ethyl‐2‐picolinoylhydrazine	
carbothioamide	(EPHC)		
EPHC	was	synthesized	by	boiling	1	mmol	of	2‐picolinic	acid	
hydrazide	with	1	mmol	 ethyl	 isothiocyanate	 in	 ethanol	 under	
reflux	for	3	h	as	given	in	Scheme	3.	
	
2.2.2.	Synthesis	of	thiosemicarbazone	complexes		
	
All	 complexes	 were	 prepared	 by	 refluxing	 an	 ethanolic	
solution	 of	 the	 thiosemicarbazone	 (EPHC)	 ligand	 (1	 mmol;	
0.224	 g)	 and	 1,10‐phenanthroline	 heterocyclic	 base	 (1	mmol;	
0.1982	 g)	 with	 an	 ethanolic	 solution	 of	 metal	 salt	 (1	 mmol,	
CuCl2.2H2O,	0.1702	g;	CoCl2.6H2O,	0.238	g;	NiCl2.6H2O,	0.237	g;	
MnCl2.4H2O,	 0.1979)	 in	 the	 molar	 ratio	 1:1:1	 (w:w:w).	 The	
reaction	mixtures	were	 refluxed	 on	 a	water	 bath	 for	 4	 h	 and	
allowed	 to	 cool	 to	 room	 temperature	 overnight.	 The	
precipitated	 complexes	 were	 then	 filtered	 off,	 washed	 with	
petroleum	ether	and	dried	overnight	in	a	vacuum	desiccator.		
	
2.3.	Molecular	modeling	
	
An	 attempt	 to	 gain	 a	 better	 insight	 on	 the	 molecular	
structure	 of	 these	 synthesized	 thiosemicarbazone	 compounds	
and	 their	 M(II)‐complexes,	 geometric	 optimization	 and	
conformation	 analysis	 has	 performed	 using	 semiempirical	
parameterized	PM3	method	as	implemented	in	HyperChem	7.5	
[25].	Convergence	criteria	were	set	to	0.01	kcal/mol.Å	for	PM3	
calculations.	
	
2.4.	Biological	activity	
	
The	antibacterial	investigation	of	the	free	(EPHC)	ligand	or	
its	Mn(II),	 Co(II),	 Cu(II)	 and	Ni(II)	 complexes	was	 carried	 out	
using	 a	modified	Kirby‐Bauer	 disc	 diffusion	method	 [26].	 The	
test	was	 done	 against	 filamentous	 fungi	 as	 (Aspergillus	 flavus	
RCMB	02568,	Pencicillium	 italicum	 (RCMB	03924),	Aspergillus	
flavus	 (RCMB	 02568))	 at	 30	 °C	 for	 24‐48	 hours;	 Gram	 (+)	
bacteria	 as	 (Bacillus	 subtillis	 RCMB	 010067,	 Staphylococcus	
aureus	 RCMB	 010028);	 Gram	 (‐)	 bacteria	 as	 (Pseudomonas	
aeuroginosa	 RCMB	 010043,	 Escherichia	 coli	 RCMB	 010052).	
The	 standard	 antibacterial	 agents	 used	 are	 Gentamicin	 for	 G‐,	
Ampicillin	for	G+	and	Amphotericin	B	(Antifungal	agent)	served	
as	 positive	 controls	 while	 DMSO,	 which	 exhibited	 no	
antimicrobial	activity,	was	used	as	a	negative	control.	The	agar	
used	 is	 Mueller‐Hinton	 agar	 that	 is	 rigorously	 tested	 for	
composition	and	pH.		
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Table	1.	Analytical	and	physical	data	of	synthesized	compounds.	
Compound	 Formula	 Yield	(%)	 %	Calculated	(Found)	
C H N	 S	 Cl
EPHC	 C9H12N4OS	 77 48.20
(48.18)	
5.39
(5.36)	
24.98	
(24.82)	
14.30	
(14.28)	
‐
(‐)	
[Cu(EPHC)(1,10‐phen)Cl]	(1)	 C21H19N6OSCuCl 85 50.15
(50.21)	
3.78
(3.80)	
16.71	
(16.70)	
6.36	
(6.47)	
7.06
(7.09)	
[Ni(EPHC)(1,10‐phen)Cl].H2O	(2)		 C21H19N6OSNiCl.H2O 82 48.93
(48.98)	
4.07
(4.09)	
16.31	
(16.35)	
6.21	
(6.25)	
6.89
(6.91)	
[Co(EPHC)(1,10‐phen)Cl].H2O	(3)	 C21H19N6OSCoCl.H2O	 79	 48.84	
(48.89)	
4.07	
(4.11)	
16.28	
(16.31)	
6.20	
(6.25)	
6.88	
(6.91)	
[Mn(EPHC)(1,10‐phen)Cl].2H2O	(4)	 C21H19N6OSMnCl.2H2O	 81	 47.54	
(47.59)	
4.34	
(4.40)	
15.84	
(15.89)	
6.04	
(6.08)	
6.70	
(6.76)	
	
	
Table	2.	Tentative	assignment	of	the	important	infrared	bands	of	the	synthesized	complexes.		
Compounds	 υH2O	 δ(C=N)	py		 υ(C=N)py υC=S υN‐N υ(N=C)* υ(M‐N)py υ(C=N)phen	 υM‐N	 υM‐S υM‐Cl
EPHC/Phen	 ‐	 615	 1608	 1290,	830	 1115	 ‐	 ‐	 1570	 ‐	 ‐	 ‐	
[Cu(EPHC)(1,10‐phen)Cl]	(1)	 ‐	 638	 1580 1265,	805 1170 1630 290 1546	 444	 325 240
[Ni(EPHC)(1,10‐phen)Cl].H2O	(2)		 3450	 633	 1585	 1265,	810	 1185	 1625	 278	 1550	 438	 323	 238	
[Co(EPHC)(1,10‐phen)Cl].H2O	(3)	 3428	 625	 1590 1250,	805 1191 1623 280 1551	 431	 333 222
[Mn(EPHC)(1,10‐phen)Cl].2H2O	(4)	 3460	 623	 1592 1249,	802 1177 1619 282 1554	 430	 335 225
*	A	new	band	appears	in	the	complexes	due	to	the	thiolating	of	the	(C=S)	group.	
	
	
Plates	were	 incubated	with	 filamentous	 fungi	 at	 30	 °C	 for	
24‐48	hours	and	with	bacteria	at	35‐37	°C	for	24‐48	hours	[27]	
and	 then	 the	 diameters	 of	 inhibition	 zones	were	measured	 in	
millimeters	 using	 slipping	 calipers	 of	 the	 National	 Committee	
for	Clinical	Laboratory	Standards	(NCCLS)	[28,29].		
	
3.	Results	and	discussion	
	
The	isolated	thiosemicarbazone	compound	is	formed	by	the	
interaction	 of	 2‐picolinic	 acid	 hydrazide	 with	 ethyl	 isothio‐
cyanate	under	reflux	conditions	(Scheme	3).	The	formulation	of	
the	isolated	compounds	based	on	the	elemental	analysis	(Table	
1),	 IR,	 and	 electronic	 spectra.	 The	 solid	 compounds	 are	 air	
stable.	 These	 compounds	 are	 colored,	 insoluble	 in	 H2O	 and	
other	common	organic	solvents	like	methanol	and	ethanol	but	
soluble	 in	 dimethylformamide	 (DMF)	 and	 dimethylsulphoxide	
(DMSO).	 Attempts	 to	 obtain	 single	 crystal	 suitable	 for	 X‐ray	
determination	were	unsuccessful,	thus	molecular	modeling	for	
EPHC	 thiosemicarbazone	 compound	 and	 its	 M(II)‐complexes	
were	investigated.		
	
3.1.	Infrared	spectra	
	
The	 tentative	 assignments	 of	 the	 significant	 IR	 spectral	
bands	 of	 the	 free	 EPHC	 thiosemicarbazone	 compound	 and	 its	
metal(II)	complexes	are	listed	in	Table	2.	The	characteristic	IR	
peaks	reveal	each	of	the	following:	
In	 the	spectra	of	EPHC,	 the	band	observed	at	1115	cm‐1	 is	
assigned	 to	 ν(N‐N).	 The	 increase	 in	 frequency	 of	 this	 band	 in	
the	spectra	of	complexes	due	to	the	increase	in	the	double	bond	
character	of	N‐N	[30]	 is	an	evidence	 for	 the	enethiolization	of	
the	 thiosemicarbazone	 ligand	 and	 the	 coordination	 via	 the	
azomethine	nitrogen.	The	IR	spectrum	of	EPHC	ligand	exhibits	
a	band	at	3510	cm‐1	due	to	ν(OH)	in	addition	to	ν(CO)	at	1665	
cm‐1	suggested	the	keto‐enol	tautomerism.	On	complexation	the	
band	 due	 to	 ν(CO)	 is	 absent	 indicating	 the	 coordination	 of	
EPHC	 ligand	 in	 enol	 form.	 The	 pyridine	 in‐plane	 deformation	
mode	at	615	 cm‐1	 in	 the	 spectrum	of	 the	 ligand	 shifts	 to	623‐
638	 cm‐1	 in	 spectra	 of	 the	 above	 complexes,	 suggesting	
coordination	of	 the	heteroaromatic	nitrogen.	 In	 the	 spectra	of	
all	complexes,	 the	bands	assigned	to	the	newly	formed	(N=C)*	
band	due	to	the	thiolating	of	the	(C=S)	groups	are	located	in	the	
range	1619‐1630	cm‐1.	The	 two	bands	assigned	to	δ(C=S)	and	
ν(C=S)	 appear	 at	 the	 frequencies	 1290	 and	 830	 cm‐1	
respectively	[31,32].	In	all	complexes,	these	two	bands	undergo	
weakness	and	shift	to	lower	frequencies	appearing	in	the	range	
(1249‐1260	cm‐1)	and	(802‐810	cm‐1),	respectively,	confirming	
the	 coordination	 via	 the	 thiolate	 sulfur	 atom	 [33,34].	 The	 IR	
spectrum	 of	 the	 free	 1,10‐phen	 ligand	 shows	 a	 very	 stronger	
bands	 at	 ~1570	 cm‐1	 due	 to	 stretching	 frequency	 of	 >C=N	
present	 in	1,10‐phenanthroline	moiety.	This	 band	was	 shifted	
to	 lower	 frequencies	 in	 the	 complexes	 ~16‐24	 cm‐1,	 which	
clearly	indicate	that	the	coordination	of	the	two	nitrogen	atoms	
of	the	neutral	1,10‐phen	ligand	to	M(II)	ion	upon	complexation	
[32].	 The	 coordination	 positions	 of	 the	 EPHC	 thiosemi‐
carbazone	 in	 the	M(II)	 complexes	 are	 confirmed	by	 assigning	
the	 strong	 bands	 observed	 in	 the	 far	 IR	 spectra	 of	 the	
complexes.	 The	 bands	 observed	 at	 (430‐444)	 and	 (323‐335)	
cm‐1	 are	 assigned	 to	 ν(M‐N)	 [35]	 and	 ν(M‐S)	 as	 suggested	 by	
Lever	 [36],	 respectively.	 The	 broad	 band	 centered	 at	 3428‐
3460	cm‐1	in	the	spectra	of	complexes	may	be	due	to	hydrated	
water.	In	the	literature,	the	bands	appearing	between	160	and	
300	cm‐1	are	allotted	to	the	vibration	of	the	M‐X	bonds	where	M	
=	 Metal	 and	 X	 =	 Cl	 or	 Br	 [37,38].	 In	 our	 case	 the	 ν(M‐Cl)	
frequencies	 appearing	 between	 225‐240	 cm‐1	 are	 in	 good	
agreement	with	the	reported	values	in	the	literature.	Based	on	
the	 above	 spectral	 evidences,	 it	 is	 confirmed	 that	 the	
thiosemicarbazone	 ligands	 lost	 the	NH	proton	attached	to	C=S	
and	 coordinated	 to	 the	 M(II)	 ion	 as	 mononegative	 tridentate	
anion,	 coordinating	 via	 the	 azomethine	 and	 pyridine	 nitrogen	
atoms	and	the	thiolate	sulfur	atom	after	deprotonation.		
	
3.2.	Electronic	spectra		
	
The	 probable	 assignments	 for	 the	 bands	 in	 the	 region	
28150	 and	 33242	 cm‐1	 are	 due	 to	 the	 n	 →	 π*	 and	 π	 →	 π*	
transitions	 of	 thiosemicarbazone	 compound	 respectively.	
Always	n	→	π*	transitions	occurs	at	a	lower	energy	than	π	→	π*	
transitions	 [39].	 In	 the	 spectra	 of	 M(II)	 complexes	 the	 bands	
observed	 in	 the	region	27320‐27880	cm‐1	are	assigned	 to	S	→	
M	 charge‐transfer	 band	 [40].	 The	 bands	 in	 the	 range	 31260‐
31588	cm‐1	observed	 in	 the	spectra	of	all	M(II)	complexes	are	
assigned	as	Cl	→	M	charge‐transfer	transitions	[41].	The	shift	of	
the	π	→	π*	bands	to	the	longer	wavelength	region	is	the	result	
of	the	C=S	bond	being	weakened	and	conjugation	system	being	
enhanced	after	the	formation	of	the	complex	[42].	The	magnetic	
moment	of	Mn(II)	complex	(6.11	B.M.)	is	corresponding	to	five	
unpaired	electrons,	 as	expected	 for	high	spin	3d5	system	[43].	
The	 electronic	 spectrum	 of	 this	 complex	 show	 two	 bands	 at	
20,250	and	24,850	cm‐1	attributable	to	6A1g	→	6T1g(G)	and	6A1g	
→	6T2g(G),	respectively,	suggesting	an	octahedral	structure	[43].		
The	 Co(II)	 complexes	 generally	 give	 rise	 to	 three	
absorption	 bands	 in	 the	 visible	 region	 under	 the	 influence	 of	
the	octahedral	 field	by	 the	excitation	of	 the	electron	 from	 the	
ground	state	4T1g	(F)	to	the	excited	states	4T2g	(F),	4A2g	(F)	and	
4T1g	(P).		
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Table	3.	Molar	conductance,	magnetic	moment	and	electronic	spectral	data	(cm‐1)	of	the	complexes.	
Compounds	 ΛMa	 µeff.	(B.M.)	 d‐d	 Transitions	
[Cu(EPHC)(1,10‐phen)Cl]	(1)	 3.15 1.82 14585 2B1g→2Eg	
[Ni(EPHC)(1,10‐phen)Cl]	(2)		 4.99 3.11 10265
16940	
3A2g→3T1g(F)	
3A2g→3T1g(P)	
[Co(EPHC)(1,10‐phen)Cl].H2O	(3)	 5.35	 4.63	 9725	
21010	
4T1g(F)	→4T2g(F)	
4T1g(F)	→4T1g(P)	
[Mn(EPHC)(1,10‐phen)Cl].H2O	(4)	 6.97	 6.11	 20250	
24850	
6A1g	→	6T1g(G)	
6A1g	→	6T2g(G)	
a	Molar	conductance	measured	for	10‐3	M	DMSO	solution,	Ω‐1	cm2	mol‐1.	
	
	
In	the	Co(II)	complex,	only	two	bands	are	observed	at	9725	
cm–1	 4T1g(F)	→	 4T2g(F)	 (1)	 and	 21,010	 cm–1	 4T1g(F)	→	 4T1g(P)	
(3)	 as	 reported	 in	 many	 octahedral	 cobalt(II)	 complexes	
[44,45].	The	ν2	 transition	was	not	observed	due	 to	very	weak	
intensity.	The	value	of	the	magnetic	moment	4.63	B.M.	(normal	
range	 for	 octahedral	 Co(II)	 complexes	 is	 4.3‐5.2	 B.M.)	 is	 an	
additional	 evidence	 for	 an	 octahedral	 geometry	 around	 the	
Co(II)	ion	[46].	
The	 copper(II)	 complex	 exhibit	 magnetic	moment	 of	 1.82	
B.M.	at	room	temperature.	This	value	is	quite	close	to	the	spin	
allowed	 values	 expected	 for	 a	 S	 =	 1/2	 system	 and	 may	 be	
indicative	of	a	distorted	octahedral	geometry	around	copper(II)	
ion.	 This	 copper(II)	 complex	 displays	 a	 broad	 band	 at	 14,585	
cm‐1	due	to	2B1g	→	2Eg	assigned	to	d‐d	transitions	of	a	distorted	
octahedral	environment	[47,48].		
The	electronic	spectra	of	the	nickel(II)	complexes	exhibited	
absorption	 bands	 at	 10,265	 and	 16,940	 cm‐1,	 attributable	 to	
3A2g	→	3T1g(F)	and	3A2g	→	3T1g(P),	transitions,	respectively,	in	an	
octahedral	 geometry	 [44,48].	 Also,	 the	 value	 of	 the	 magnetic	
moment	 (3.11	 B.M.)	may	 be	 taken	 as	 additional	 evidence	 for	
their	 octahedral	 structure.	 On	 the	 basis	 of	 the	 above	
observations,	 it	 is	 tentatively	 suggested	 that	 all	 of	 the	
complexes	 show	 an	 octahedral	 geometry	 in	 which	 the	 EPHC	
thiosemicarbazone	 ligand	 act	 as	monoanion	 tridentate	 ligand,	
1,10‐phen	 acts	 as	 bidentate	 ligand	 and	 in	 addition	 to	 the	
monodentate	 chloride	 ion.	 These	 possibly	 accommodate	
themselves	around	the	metal	atom	in	such	a	way	that	a	stable	
chelate	 ring	 is	 formed	 giving,	 in	 turn,	 stability	 to	 the	 metal	
complexes.	
	
3.3.	ESR	spectrum	of	[Cu(EPHC)(1,0‐phen)Cl]	complex	
	
ESR	spectroscopy	is	a	direct	measurement	of	electron	spin	
when	there	are	unpaired	electrons	within	a	chemical	structure	
and	thus	provides	a	way	to	investigate	the	electronic	spin	state	
and	oxidation	state	of	the	coordinated	metal	ion.	Also,	the	ESR	
spectra	of	the	complexes	is	important	in	studying	the	metal	ion	
environment	 in	 the	 complexes,	 such	 as	 geometry,	 nature	 of	
ligation	 sites	 from	 the	 ligand	 to	 the	metal,	 and	 the	 degree	 of	
covalence	 of	 the	 metal‐ligand	 bonds.	 The	 room	 temperature	
powder	ESR	spectrum	of	[Cu(EPHC)(1,10‐phen)Cl]	exhibits	an	
axial	 signal	with	 two	g	values	 (g||	=	2.281,	g┴	=	2.065).	The	g||	
and	g┴	values	are	computed	from	the	spectrum	using	DPPH	free	
radical	as	"g"	marker.	The	ordering	of	g	values	(g||	>	g┴	>	2.003)	
observed	 for	 copper(II)	 complex	 indicates	 that	 the	 unpaired	
electron	 is	 localized	 in	 (dx2‐y2)	 orbital	 [49]	 of	 the	 Cu(II)	 ion	
(spectroscopic	 state	 2B1g)	 and	 the	 spectral	 features	 are	
characteristics	 of	 axial	 symmetry	 [50].	 g||	 is	 a	 moderately	
sensitive	 function	 for	 M‐L	 bond	 nature.	 The	 g||	 value	 is	 a	
moderately	 sensitive	 function	 for	M‐L	 bond	nature	 i.e.,	 the	 g||	
value	 <	 2.3	 g||	 value	 >	 2.3	 are	 characterized	 for	 covalent	 and	
ionic	 metal‐ligand	 bonds	 respectively.	 By	 applying	 this	
criterion,	 the	 g||	 value	 is	 less	 than	 2.3	 is	 an	 indication	 of	
significant	 covalent	 bonding	 in	 copper(II)	 complex.	 Based	 on	
elemental	 analysis,	 IR,	 electronic	 spectra	 and	ESR	data,	 Cu(II)	
complex	has	octahedral	structure.	The	geometric	parameter	G,	
which	is	a	measure	of	the	exchange	interaction	between	copper	
centers	 in	 the	 polycrystalline	 compound,	 is	 calculated	 using	
Hathway	expression	(G	=	g||‐2.0023/g┴‐2.0023)	[51].	According	
to	 Hathway,	 if	 the	 value	 of	 G	 >	 4,	 the	 exchange	 interaction	 is	
negligible	 in	 solid	 complexes	but	G	<	4	 indicates	 considerable	
interaction	 in	 solid	 complexes	 [51].	 In	 the	 Cu(II)	 complex	
reported	in	 this	paper,	 the	G	value	(4.445)	>	4,	suggesting	the	
absence	 of	 copper‐copper	 exchange	 interactions	 in	 the	 solid	
state.		
		
3.4.	Conductivity	measurements	
	
Conductivity	measurements	in	non‐aqueous	solutions	have	
frequently	 been	 used	 in	 structural	 studies	 of	 metal	 chelates	
within	the	limits	of	their	solubility.	These	measurements	were	
provided	 a	method	 for	 testing	 the	 degree	 of	 ionization	 of	 the	
complexes,	the	molar	ions	that	a	complex	liberates	in	solution,	
the	 higher	 will	 be	 its	molar	 conductivity	 and	 vice	 versa.	 The	
non‐ionized	 complexes	 have	 negligible	 value	 of	 molar	
conductance.	 It	 is	 clear	 from	 the	 conductivity	 data	 (Table	 3)	
that	 the	 complexes	 present	 seem	 to	 be	 nonelectrolytes	 (3.15‐
6.97	Ω‐1.cm2.mol‐1).	Also	the	molar	conductance	values	indicate	
that	 the	 anions	 were	 existed	 inside	 the	 coordination	 sphere,	
which	was	also	confirmed	from	the	chemical	analysis	and	also	
Cl−	ion	is	not	precipitated	by	addition	of	AgNO3	solution.	Hence,	
the	 conductivity	 measurements	 of	 the	 metal(II)‐chelates	
confirm	 the	 proposed	 general	 formulae	 of	 those	 chelates	 as	
suggested	 depending	 upon	 the	 results	 of	 elemental	 analyses,	
UV‐Vis,	ESR	and	IR	spectra.	
	
3.5.	Antimicrobial	activity	
	
To	 assess	 the	 biological	 potential	 of	 the	 synthesized	
compounds,	 the	 thiosemicarbazone	 ligands	 and	 their	 metal	
complexes	were	tested	against	different	species	of	bacteria	and	
fungi.	 The	 parent	 (EPHC)	 ligand	 and	 its	 complexes	 are	water	
insoluble;	 therefore,	 the	 antimicrobial	 test	was	 carried	 out	 in	
DMSO.	The	results	of	the	antimicrobial	test	of	the	parent	ligand	
and	 its	 metal	 complexes	 against	 Gram	 positive	 and	 Gram	
negative	are	given	in	Table	4	while	the	results	of	the	antifungal	
activity	 against	 was	 given	 in	 Table	 5.	 In	 testing	 the	
antimicrobial	activity	of	these	compounds,	we	used	more	than	
one	test	organism	to	increase	the	chance	of	detecting	antibiotic	
principles	 in	 tested	 materials.	 The	 organisms	 used	 in	 the	
present	 investigations	 included	 two	 Gram	 positive	
(Staphylococcus	 aureus	 and	 Bacillus	 subtillis)	 and	 two	 Gram	
negative	 (Pseudomonas	aeruguinosa	and	Escherichia	 coli).	 The	
diffusion	agar	technique	was	used	to	evaluate	the	antibacterial	
activity	of	the	synthesized	mixed	ligand	complexes	[52‐55].	The	
medium	 used	 for	 growing	 the	 culture	was	 nutrient	 agar.	 The	
results	 of	 the	 antibacterial	 activity	 of	 the	 synthesized	
compounds	 are	 recorded	 in	 Tables	 4	 and	 5.	 Metal	 ions	 are	
adsorbed	 on	 the	 cell	 walls	 of	 the	microorganisms,	 disturbing	
the	 respiration	 processes	 of	 the	 cells	 and	 thus	 blocking	 the	
protein	 synthesis	 that	 is	 required	 for	 further	 growth	 of	 the	
organisms.	 Hence,	 metal	 ions	 are	 essential	 for	 the	 growth‐
inhibitory	effects	[56].	The	synthesized	compounds	were	found	
to	 be	 more	 toxic	 compared	 with	 their	 parent	 free	 ligands	
against	 the	 same	 micro‐organism	 and	 under	 the	 identical	
experimental	conditions.		
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Table	4.	Antibacterial	activity	of	thiosemicarbazone	ligand	and	its	metal	complexes.	
Compounds	 Diameter	of	inhibition	zone	(in	mm)	a	
(G‐)	 (G+)
Escherichia	coli	
(RCMB	010052)	
Pseudomonas	aeuroginosa
(RCMB	010043)	
Staphylococcus	aureus	
(RCMB	010028)	
Bacillus	subtillis
(RCMB	010067)	
EPHC	 11.2±0.52	 12.2±0.34	 20.1±0.45	 19.9±0.79	
[Cu(EPHC)(1,10‐phen)Cl]	(1)	 19.9±0.47	 17.1±0.19 31.2±0.25 26.7±0.62
[Ni(EPHC)(1,10‐phen)Cl].H2O	(2)		 16.4±0.44	 16.4±0.22	 28.7±0.24	 25.3±0.32	
[Co(EPHC)(1,10‐phen)Cl].H2O	(3)	 15.8±0.53	 13.8±0.34	 24.9±0.65	 22.3±0.69	
[Mn(EPHC)(1,10‐phen)Cl].2H2O	(4)	 14.5±0.25	 13.1±0.25 23.8±0.39 20.8±0.87
Standard	b	 	22.3±0.18	 17.3±0.15 32.4±0.10 27.4±0.18
a	 Mean	 zone	 of	 inhibition	 in	 mm±standard	 deviation	 beyond	 well	 diameter	 (6	 mm)	 produced	 on	 a	 range	 of	 environmental	 and	 clinically	 pathogenic	
microorganisms	using	(1	mg/mL)	concentration	of	tested	samples.	
b	The	standard	antibacterial	agents	used	are	Gentamicin	for	G‐	and	Ampicillin	for	G+.	
	
	
Table	5.	Antifungal	activity	of	thiosemicarbazone	ligand	and	its	metal	complexes.	
Compounds	 Diameter	of	inhibition	zone	(in	mm)	a	
Aspergillus	flavus
(RCMB	02568)	
Pencicillium	italicum
(RCMB	03924)	
Geotricum	candidum
(RCMB	05097)	
EPHC	 12.6±0.58	 13.2±0.24	 15.7±0.29	
[Cu(EPHC)(1,10‐phen)Cl]	(1)	 22.9±0.50 18.2±0.38 26.5±0.18	
[Ni(EPHC)(1,10‐phen)Cl].H2O	(2)		 21.2±0.58 16.9±0.54 24.4±0.32	
[Co(EPHC)(1,10‐phen)Cl].H2O	(3)	 20.6±0.25	 14.7±0.24	 21.7±0.75	
[Mn(EPHC)(1,10‐phen)Cl].2H2O	(4)	 18.6±0.47 14.1±0.37 19.8±0.53	
Amphotericin	(B)	 23.7±0.10 21.9±0.12 28.7±0.22	
a	 Mean	 zone	 of	 inhibition	 in	 mm±standard	 deviation	 beyond	 well	 diameter	 (6	 mm)	 produced	 on	 a	 range	 of	 environmental	 and	 clinically	 pathogenic	
microorganisms	using	(1	mg/mL)	concentration	of	tested	samples.	
	
	
According	 to	 Overtone’s	 concept	 of	 cell	 permeability,	 the	
lipid	membrane	 that	 surrounds	 the	 cell	 favors	 the	 passage	 of	
only	 lipid‐soluble	 materials,	 so	 lipophilicity	 is	 an	 important	
factor	 controlling	 the	 antifungal	 activity.	 Upon	 chelating,	 the	
polarity	of	the	metal	 ion	will	be	reduced	due	to	the	overlap	of	
the	ligand	orbitals	and	partial	sharing	of	the	positive	charge	of	
the	metal	 ion	with	donor	groups.	 In	addition,	chelation	allows	
for	the	delocalization	of	π‐electrons	over	the	entire	chelate	ring	
and	enhances	the	lipophilicity	of	the	complexes.	This	increased	
lipophilicity	 facilitates	 the	 penetration	 of	 the	 complexes	 into	
lipid	 membranes,	 further	 restricting	 proliferation	 of	 the	
microorganisms.	The	variation	in	the	effectiveness	of	different	
compounds	against	different	organisms	depends	either	on	the	
impermeability	 of	 the	microbial	 cells	 or	 on	 differences	 in	 the	
ribosomes	 of	 the	 cells	 [57‐59].	 All	 of	 the	 metal	 complexes	
possess	 higher	 antifungal	 activity	 than	 the	 ligand	 [60‐63].	
Although	 the	 exact	 biochemical	mechanism	 is	 not	 completely	
understood,	 the	mode	of	 action	of	 antimicrobials	may	 involve	
various	 targets	 in	 the	 microorganisms.	 These	 targets	 include	
the	following.		
(i) The	higher	activity	of	the	metal	complexes	may	be	due	to	
the	different	properties	of	the	metal	ions	upon	chelation.	
The	polarity	of	the	metal	ions	will	be	reduced	due	to	the	
overlap	 of	 the	 ligand	 orbitals	 and	 partial	 sharing	 of	 the	
positive	charge	of	the	metal	ion	with	donor	groups.	Thus,	
chelation	enhances	the	penetration	of	the	complexes	into	
lipid	membranes	and	the	blockage	of	metal	binding	sites	
in	the	enzymes	of	the	microorganisms	[64].		
(ii) Tweedy’s	chelation	theory	predicts	that	chelation	reduces	
the	polarity	of	 the	metal	atom	mainly	because	of	partial	
sharing	 of	 its	 positive	 charge	 with	 donor	 groups	 and	
possible	electron	delocalization	over	the	entire	ring.	This	
consequently	 increases	 the	 lipophilic	 character	 of	 the	
chelates,	 favoring	 their	 permeation	 through	 the	 lipid	
layers	of	the	bacterial	membrane	[65].		
(iii) Interference	with	 the	synthesis	of	cellular	walls,	 causing	
damage	 that	 can	 lead	 to	 altered	 cell	 permeability	
characteristics	or	disorganized	lipoprotein	arrangements,	
ultimately	resulting	in	cell	death.		
(iv) Deactivation	of	various	cellular	enzymes	that	play	a	vital	
role	in	the	metabolic	pathways	of	these	microorganisms.		
(v) Denaturation	 of	 one	 or	 more	 cellular	 proteins,	 causing	
the	normal	cellular	processes	to	be	impaired.		
(vi) Formation	 of	 a	 hydrogen	 bond	 through	 the	 azomethine	
group	 with	 the	 active	 centers	 of	 various	 cellular	
constituents,	 resulting	 in	 interference	 with	 normal	
cellular	 processes	 [66‐68].	 The	 tested	 complexes	 were	
more	 active	 against	 Gram‐positive	 than	 Gram‐negative	
bacteria,	 it	 may	 be	 concluded	 that	 the	 antibacterial	
activity	of	the	compounds	is	related	to	cell	wall	structure	
of	the	bacteria	(Figure	1	and	2).		
	
	
Figure	1.	Antibacterial	activity	of	M(II)‐complexes	towards	different	types	of	
bacterial	strains.	
	
	
Figure	2.	Antifungal	 activity	 of	M(II)‐complexes	 towards	different	 types	 of	
fungal	strains.	
	
It	 is	 possible	 because	 the	 cell	 wall	 is	 essential	 to	 the	
survival	 of	bacteria	 and	 some	antibiotics	 are	 able	 to	 kill	
bacteria	 by	 inhibiting	 a	 step	 in	 the	 synthesis	 of	
peptidoglycan.	Gram‐positive	bacteria	possess	a	thick	cell	
wall	 containing	 many	 layers	 of	 peptidoglycan	 and	
teichoic	 acids,	 but	 in	 contrast,	 Gram	 negative	 bacteria	
have	a	relatively	thin	cell	wall	consisting	of	a	few	layers	of	
peptidoglycan	 surrounded	 by	 a	 second	 lipid	 membrane	
containing	lipopolysaccharides	and	lipoproteins.		
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Table	6.	Some	energetic	properties	of	EPHC	thiosemicarbazone	and	its	complexes	calculated	by	PM3	method.	
Ligand	 Total	energy	
(kcal/mol)	
Binding	energy	
(kcal/mol)	
Electronic	energy	
(kcal/mol)	
Dipole	moment		
(Debye)	
HOMO	
(eV)	
LUMO		
(eV)	
EPHC	 ‐54843.90	 ‐2698.41	 ‐322610.60	 1.95	 ‐9.02	 ‐0.90	
[Cu(EPHC)(1,10‐phen)Cl]	(1)	 ‐132278.40	 ‐5495.28	 ‐1119311.52	 5.25	 ‐3.62	 ‐0.96	
[Ni(EPHC)(1,10‐phen)Cl].H2O	(2)		 ‐128997.47	 ‐5624.97	 ‐1128540.07	 11.91	 ‐6.21	 ‐2.18	
[Co(EPHC)(1,10‐phen)Cl].H2O	(3)	 ‐123307.98	 ‐5800.93	 ‐1102050.97	 5.50	 ‐3.52	 ‐1.73	
[Mn(EPHC)(1,10‐phen)Cl].2H2O	(4)	 ‐114017.78	 ‐5553.96 ‐1054657.86 2.95 ‐3.71	 ‐1.15
	
	
Table	7.	Bond	distances	(Å)	and	angles	(°)	for	EPHC	compound.	
Atoms	 Bond	distances	(Å)	 Atoms Angle	(°)	
C(13)‐C(15)	 1.5142	 C(15)‐C(13)‐N(12)	 111.1151	
N(12)‐C(13)	 1.4836	 C(13)‐N(12)‐C(11) 120.7721	
C(11)‐S(14)	 1.6607	 S(14)‐C(11)‐N(12) 124.3345	
C(11)‐N(12)	 1.3900	 S(14)‐C(11)‐N(10) 123.1882	
N(10)‐C(11)	 1.4266	 N(12)‐C(11)‐N(10) 112.4562	
N(9)‐N(10)	 1.4474	 C(11)‐N(10)‐N(9) 118.9549	
C(7)‐N(9)	 1.4543	 N(10)‐N(9)‐C(7) 115.3396	
C(7)‐O(8)	 1.2126	 N(9)‐C(7)‐O(8)	 120.8053	
C(5)‐C(7)	 1.4997	 N(9)‐C(7)‐C(5) 114.2262	
C(5)‐C(6)	 1.3976	 O(8)‐C(7)‐C(5)	 124.8760	
N(4)‐C(5)	 1.3581	 C(5)‐C(6)‐C(1)	 118.6875	
C(3)‐N(4)	 1.3496	 C(7)‐C(5)‐C(6)	 121.1215	
C(2)‐C(3)	 1.3972	 C(7)‐C(5)‐N(4) 117.1474	
C(1)‐C(6)	 1.3934	 C(6)‐C(5)‐N(4) 121.7192	
C(1)‐C(2)	 1.3902	 C(5)‐N(4)‐C(3) 119.4206	
	 N(4)‐C(3)‐C(2) 121.5728	
	 C(3)‐C(2)‐C(1) 119.1281	
	 C(6)‐C(1)‐C(2) 119.4708	
	
	
	
These	 differences	 in	 cell	 wall	 structure	 can	 produce	
differences	 in	 antibacterial	 susceptibility	 and	 some	
antibiotics	 can	 kill	 only	 Gram‐positive	 bacteria	 and	 is	
ineffective	against	Gram‐negative	pathogens	[69,70].	It	is	
worth	 noting	 that	 the	 comparison	 of	 antimicrobial	
activities	of	the	compounds	against	the	selected	types	of	
microorganisms	 indicate	 that	 Cu(II)	 >	 Ni(II)	 >	 Co(II)	 >	
Mn(II).		
	
3.6.	Molecular	modeling	
	
The	atomic	numbering	 scheme	as	 given	 in	Figure	3‐5	and	
the	theoretical	geometry	structures	for	the	ligand	and	some	of	
its	metal	complexes	are	calculated.	The	molecular	parameters:	
total	energy,	binding	energy,	isolated	atomic	energy,	electronic	
energy,	 heat	 of	 formation,	 dipole	 moment,	 HOMO	 and	 LUMO	
were	 calculated	 and	 represented	 in	 Table	 6.	 A	 comparison	
between	 the	 bond	 length	 of	 the	 ligand	 and	 its	 complexes	 is	
illustrated.	 All	 the	 active	 groups	 taking	 part	 in	 coordination	
have	 bonds	 longer	 than	 that	 already	 exist	 in	 the	 ligand	 (like	
C=N,	C=S).	The	lower	HOMO	energy	values	show	that	molecule	
donating	electron	ability	is	the	weaker.	On	contrary,	the	higher	
HOMO	 energy	 implies	 that	 the	 molecule	 is	 a	 good	 electron	
donor.	 LUMO	 energy	 presents	 the	 ability	 of	 a	 molecule	
receiving	electron	[22,71].		
	
	
	
	
Figure	3.	The	optimized	 structural	 geometry	 of	 EPHC	 along	with	 the	 atom	
numbering	scheme.	
	
	
	
	
Figure	4.	The	optimized	structural	geometry	of	[Ni(EPHC)(1,10‐phen)Cl]	(2)	
along	with	the	atom	numbering	scheme.	
	
	
The	 bond	 lengths	 and	 bond	 angles	 of	 EPHC‐thiosemi‐
carbazone	 ligand	 and	 [Mn(EPHC)(1,10‐phen)Cl]	 complex	 as	 a	
representative	example	of	M(II)	compounds	are	given	in	Table	
7	 and	 8,	 respectively.	 A	 drawing	 of	 EPHC‐thiosemicarbazone	
ligand	 is	 shown	 in	Figure	3	while	Ni(II)	 and	Co(II)	 complexes	
with	the	atomic	numbering	scheme	is	shown	in	Figure	4	and	5,	
respectively.	 The	 coordination	 results	 in	 the	 changes	 of	 bond	
lengths	 and	 angles	 of	 the	 thiosemicarbazone	 moiety,	 as	
expected,	 thus	 when	 the	 bond	 lengths	 in	 the	 coordinated	
thiosemicarbazone	 ligand	are	compared	with	those	 in	the	free	
thiosemicarbazone	ligand,	it	is	seen	that	coordination	elongates	
the	 thiosemicarbazone	 moiety’s	 C–S	 bond	 from	 1.660	 Å	 to	
1.729‐1.811	Å	and	contracts	adjacent	N–C(S)	bond	from	1.426	
Å	 to	 1.313‐1.361	 Å	 in	 ,	 which	 is	 consistent	 with	 the	 C–S	
acquiring	 a	 partial	 single	 bond	 and	 N–C(S)	 a	 partial	 double	
bond	character.	These	changes	in	bond	lengths	are	attributable	
to	 stabilization	 of	 the	 iminothiolate	 form	 of	 the	 thiosemi‐
carbazone	ligand	upon	complexation	via	loss	of	the	hydrazinic	
proton	[72].		
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Table	8.	Bond	distances	(Å)	and	angles	(o)	for	[Mn(EPHC)(phen)Cl]	complex.	
Atoms	 Bond	distances	(Å)	 Atoms	 Angle	(°)	 Atoms	 Angle	(°)	
C(30)‐N(31)	 1.4013	 C(30)‐N(31)‐C(26) 115.3974 C(16)‐N(15)‐C(13)	 122.7854
C(29)‐C(30)	 1.3793	 C(30)‐N(31)‐Mn(11) 129.9560 C(13)‐S(14)‐Mn(11)	 93.9839
C(28)‐C(29)	 1.4036	 C(26)‐N(31)‐Mn(11)	 114.4310	 N(15)‐C(13)‐S(14)	 119.6797	
C(27)‐C(28)	 1.4005	 N(31)‐C(30)‐C(29)	 121.5916	 N(15)‐C(13)‐N(9)	 116.4556	
C(26)‐N(31)	 1.4166	 C(30)‐C(29)‐C(28)	 122.0829	 S(14)‐C(13)‐N(9)	 123.8348	
C(26)‐C(27)	 1.4076	 C(29)‐C(28)‐C(27)	 118.8145	 N(31)‐Mn(11)‐N(22)	 85.1370	
C(24)‐C(25)	 1.3735	 C(28)‐C(27)‐C(26) 117.8240 N(31)‐Mn(11)‐S(14)	 103.5590
C(23)‐C(24)	 1.4222	 C(28)‐C(27)‐C(19) 124.6801 N(31)‐Mn(11)‐Cl(12)	 156.8913
N(22)‐C(23)	 1.3367	 C(26)‐C(27)‐C(19) 117.4928 N(31)‐Mn(11)‐N(8)	 101.1144
C(21)‐N(22)	 1.4030	 N(31)‐C(26)‐C(27) 124.2319 N(31)‐Mn(11)‐N(7)	 85.2175
C(21)‐C(26)	 1.4135	 N(31)‐C(26)‐C(21) 115.1995 N(22)‐Mn(11)‐S(14)	 90.8034
C(20)‐C(25)	 1.4159	 C(27)‐C(26)‐C(21) 120.5656 N(22)‐Mn(11)‐Cl(12)	 85.0861
C(20)‐C(21)	 1.4060	 C(24)‐C(25)‐C(20) 119.1748 N(22)‐Mn(11)‐N(8)	 173.7317
C(19)‐C(27)	 1.4349	 C(25)‐C(24)‐C(23)	 121.2291	 N(22)‐Mn(11)‐N(7)	 99.6526	
C(18)‐C(20)	 1.4266	 C(24)‐C(23)‐N(22)	 121.4085	 S(14)‐Mn(11)‐Cl(12)	 97.4653	
C(18)‐C(19)	 1.3662	 C(23)‐N(22)‐C(21) 117.3742 S(14)‐Mn(11)‐N(8)	 87.2966
C(16)‐C(17)	 1.5154	 C(23)‐N(22)‐Mn(11)	 132.2493	 S(14)‐Mn(11)‐N(7)	 166.9528	
N(15)‐C(16)	 1.4831	 C(21)‐N(22)‐Mn(11) 110.3765 Cl(12)‐Mn(11)‐N(8)	 89.2363
C(13)‐N(15)	 1.3786	 C(26)‐C(21)‐N(22) 114.8215 Cl(12)‐Mn(11)‐N(7)	 75.8655
C(13)‐S(14)	 1.7919	 C(26)‐C(21)‐C(20) 121.3150 N(8)‐Mn(11)‐N(7)	 81.4774
Mn(11)‐N(31)	 1.8500	 N(22)‐C(21)‐C(20) 123.8621 C(13)‐N(9)‐N(8)	 113.3163
Mn(11)‐N(22)	 1.9985	 C(25)‐C(20)‐C(21) 116.9490 Mn(11)‐N(8)‐N(9)	 121.5031
Mn(11)‐S(14)	 2.2451	 C(25)‐C(20)‐C(18) 125.3884 Mn(11)‐N(8)‐C(1)	 116.6753
Mn(11)‐Cl(12)	 2.3074	 C(21)‐C(20)‐C(18)	 117.6625	 N(9)‐N(8)‐C(1)	 121.3887	
N(9)‐C(13)	 1.3510	 C(27)‐C(19)‐C(18) 121.6815 Mn(11)‐N(7)‐C(6)	 128.1585
N(8)‐Mn(11)	 1.9519	 C(20)‐C(18)‐C(19)	 121.2692	 Mn(11)‐N(7)‐C(2)	 113.2535	
N(8)‐N(9)	 1.3831	 C(17)‐C(16)‐N(15)	 111.0054	 C(6)‐N(7)‐C(2)	 118.5623	
N(7)‐Mn(11)	 2.0087	 	 	 N(7)‐C(6)‐C(5)	 121.5164	
C(6)‐N(7)	 1.3620	 	 C(6)‐C(5)‐C(4)	 119.7913
C(5)‐C(6)	 1.3935	 	 C(5)‐C(4)‐C(3)	 119.5456
C(4)‐C(5)	 1.3923	 	 C(4)‐C(3)‐C(2)	 118.9493
C(3)‐C(4)	 1.3903	 	 N(7)‐C(2)‐C(3)	 121.6342
C(2)‐C(3)	 1.3974	 	 N(7)‐C(2)‐C(1)	 113.6817
C(2)‐N(7)	 1.3861	 	 C(3)‐C(2)‐C(1)	 124.6731
C(1)‐O(10)	 1.3655	 	 	 O(10)‐C(1)‐N(8)	 127.3163	
C(1)‐N(8)	 1.3318	 	 	 O(10)‐C(1)‐C(2)	 117.8329	
C(1)‐C(2)	 1.4682	 	 	 N(8)‐C(1)‐C(2)	 114.8259	
	
	
	
	
	
Figure	5.	The	optimized	structural	geometry	of	[Co(EPHC)(1,10‐phen)Cl]	(3)	
along	with	the	atom	numbering	scheme.	
	
This	means	 that,	 C–S	 distances	which	 are	 in	 the	 range	 of	
single	bond	character	being	some	of	the	largest	found	for	M(II)	
complexes	 (typical	 bond	 lengths	 being	 C(sp2)–S	 1.706	 Å	 in	
(MeS)2C=C(SMe)2	 and	 C=S	 1.630	 Å	 in	 naphthylphenyl	
thioketone)	[73,74].	This	also	confirms	the	IR	and	spectral	data	
which	 assumed	 that	 the	 C=S	 on	 coordination	 gains	 C–S	
character.	Similar	structural	features	are	known	for	other	metal	
complexes	 of	 such	 ligands	 that	 have	 the	 same	 coordination	
sites	 [75,76].	 The	 other	 bond	 lengths	 and	 angles	 also	 suffer	
some	 changes,	 but	 not	 significantly.	 In	 general,	 the	M–S	 bond	
length	 is	 longer	 than	 that	 of	M–Cl	 for	 the	 all	M(II)	 complexes	
and	 the	 M–N	 bond	 length	 is	 shorter	 than	 M–Cl	 bond	 length	
showing	that	the	bond	length	obeyed	this	order	M–S	>	M–Cl	>	
M–N.	In	all	complexes,	C=Npy	bond	distance	of	the	pyridine	ring	
is	 elongated.	 Owing	 to	 the	 formation	 of	 the	M‐N	 bond	which	
makes	 the	 C=N	 bond	weaker	 as	 a	 result	 of	 coordination.	 The	
bond	 angles	 of	 the	 thiosemicarbazone	 moiety	 of	 EPHC	 are	
altered	 somewhat	 upon	 coordination	 and	may	 be	 reduced	 or	
increased	on	complex	 formation	as	a	consequence	of	bonding.	
The	bond	angles	around	the	M(II)	center	(≃90)	prove	that	the	
geometric	 is	 octahedral	 as	 proposed	 by	 the	 different	 tools	 of	
analysis	mentioned	previously.	Finally,	from	the	interpretation	
of	 elemental	 analysis,	 spectral	 data	 (infrared,	 electronic	 and	
ESR)	as	well	as	magnetic	susceptibility	measurements	at	room	
temperature,	conductivity	measurements	and	QM	calculations,	
it	 is	possible	to	draw	up	the	tentative	octahedral	structures	of	
the	metal	complexes.	
	
4.	Conclusions	
	
The	 reaction	 of	 2‐picolinic	 acid	 hydrazide	 with	 ethyl	
isothiocyanate	afforded	the	corresponding	N‐ethyl‐2‐picolinoyl	
hydrazinecarbothioamide	 thiosemicarbazone	 compound.	 The	
bonding	of	 ligands	to	 the	metal	 ion	 is	confirmed	by	analytical,	
spectral	 and	magnetic	measurements.	 The	 IR	 spectra	 showed	
that,	 thiosemicarbazone	compound	present	 in	 the	thione	form	
in	the	solid	state.	In	the	absence	of	X‐ray	single	crystal	data	of	
the	 current	 synthesized	 complexes	 and	 based	 on	 the	
physicochemical	 studies	 and	 geometrical	 optimization,	 a	
tentative	structure	could	be	proposed	as	shown	in	Figures	3‐5.	
M(II)‐complexes	 are	 formulated	 as	 [M(EPHC)(1,10‐
phen)Cl].nH2O	 where	 EPHC	 is	 the	 deprotonated	 thiosemi‐
carbazone	 ligand.	 In	 these	 complexes	 the	 thiosemicarbazone	
ligand	is	coordinated	to	the	metal	(II)	ion	as	a	tridentate	anion,	
coordinating	 via	 the	 azomethine	 nitrogen,	 pyridine	 nitrogen	
atoms	 and	 the	 thiolate	 sulfur	 atom	 after	 deprotonation.	 From	
elemental	analysis,	IR,	spectral,	thermal	analysis,	magnetic	and	
conductance	 measurements,	 all	 M(II)‐complexes	 are	
nonelectrolytes	with	octahedral	structure.	 In	 this	work,	 it	was	
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found	 that	 the	 M(II)	 compounds	 show	 significantly	 different	
levels	 of	 biological	 activity.	 The	 antibacterial,	 antifungal,	
screening	data	 revealed	 that	newly	 generated	 compounds	 are	
potential	antimicrobial	agents.		
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